These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23959)

  • 1. [Rat placental barrier permeability for the new antihistaminic preparation, fenkarol].
    Golovanova IV; Spryshkova RA; Golovanova EA; Chivireva AM
    Farmakol Toksikol; 1978; 41(1):65-9. PubMed ID: 23959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of the new Soviet, tritium-labelled, antihistamine preparation, phencarol].
    Kaminka ME; Spryshkova RA; Golovanova IV
    Farmakol Toksikol; 1978; 41(3):279-83. PubMed ID: 26596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the antihistamine preparation, phencarol, on the central nervous system].
    Kaminka ME; Roshchina LF; Mashkovskiĭ MD
    Farmakol Toksikol; 1980; 43(2):148-53. PubMed ID: 6108233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phencarol--an antihistaminic preparation from the quinuclidylcarbinol group].
    Kaminka WE
    Farmakol Toksikol; 1977; 40(2):158-62. PubMed ID: 15861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of new antihistaminic preparations on the body's immunologic reactivity].
    Mashkovskiĭ MD; Veksler IG; Kaminka ME; Iakimenko VA
    Biull Eksp Biol Med; 1981 Mar; 91(3):340-2. PubMed ID: 6113860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the antihistamine preparation, fencarol, and other quinuclidyldiarylcarbinols on tissue aminoxidase activity].
    Baumanis EA; Gorkin VZ; Kalninia IE; Kaminka ME; Mashkovskiĭ MD
    Farmakol Toksikol; 1980; 43(1):36-41. PubMed ID: 6103819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect on embryogenesis of a new antiallergic agent bikarfen].
    Gus'kova TA; Golovanova IV
    Farmakol Toksikol; 1981; 44(6):721-3. PubMed ID: 6118295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Placental permeability for rifampicin].
    Anufrieva RG; Zel'tser IZ; Svinogeeva TP
    Antibiotiki; 1980 Mar; 25(3):199-201. PubMed ID: 7362225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study of the antiedema activity of antihistamine preparations compared to the dynamics of their concentration in the blood serum].
    Kholodov LE; Kaverina LP; Dorokhov VV
    Farmakol Toksikol; 1985; 48(1):43-5. PubMed ID: 2858404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of pollen-induced hay fever with a new antihistaminic preparation phencarol].
    Voronkin VF; Chekanova OA
    Vestn Otorinolaringol; 1980; (6):55-8. PubMed ID: 6109389
    [No Abstract]   [Full Text] [Related]  

  • 11. [Placental permeability in rats and rabbits for thyroid hormones at different periods of pregnancy].
    Salakhova IS; Karimova ShF; Mirmakhmudova SI
    Ontogenez; 1981; 12(5):526-9. PubMed ID: 7290569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the embrotoxic properties of the repellent diethyltoluamide].
    Gleĭberman SE; Volkova AP; Nikolaev GM; Zhukova EV
    Farmakol Toksikol; 1975; 38(2):202-5. PubMed ID: 1227890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Method of determining experimentally the permeability of the placenta and other maternal and intrauterine fetal histohematic barriers].
    Tymoshenko LV; Rozumenko MB; Shramkevych AF
    Pediatr Akus Ginekol; 1979; (4):42-5. PubMed ID: 514660
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with a new Soviet antihistaminic drug, phencarol, in dermatology].
    Borisenko KK; Butov IuS; Korotkiĭ NG; Abaeva AS
    Vestn Dermatol Venerol; 1977 Apr; (4):72-5. PubMed ID: 19900
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of pharmacokinetics in realizing the embryotoxic action of drugs].
    Smol'nikova NM; Boĭko SS; Liubimov BI
    Farmakol Toksikol; 1986; 49(2):106-11. PubMed ID: 3519275
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 4th communication: placental transfer and secretion into milk in rats.
    Endo M; Yamada Y; Kohno M; Suzuki T; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):483-9. PubMed ID: 1642671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic profile and placental transfer of a single intravenous injection of [(14)C]chlorpyrifos in pregnant rats.
    Abdel-Rahman AA; Blumenthal GM; Abou-Donia SA; Ali FA; Abdel-Monem AE; Abou-Donia MB
    Arch Toxicol; 2002 Aug; 76(8):452-9. PubMed ID: 12185413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The placental transfer of cerium: experimental studies and estimates of doses to the human fetus from 141Ce and 144Ce.
    Levack VM; Hone PA; Phipps AW; Harrison JD
    Int J Radiat Biol; 2002 Mar; 78(3):227-35. PubMed ID: 11869478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryo/fetal toxicity assessment of lasofoxifene, a selective estrogen receptor modulator (SERM), in rats and rabbits.
    Ozolins TR; Gupta U
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):161-70. PubMed ID: 15282737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Placental permeability for erythromycin ascorbinate in animals previously sensitized with homologous placental protein].
    Buniatova IM
    Vopr Okhr Materin Det; 1973; 18(4):66-8. PubMed ID: 4802732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.